You are here

Glaxo presses on to find the next critical antibiotic

Despite the rise of superbugs, big pharma has largely exited antibiotic research because of low payoff
Thursday, September 22, 2016 - 05:50

Penicillin changed the world; infections that previously killed people were now treatable, paving the way for safer operations from organ transplants to hip replacements.


IN A cramped lab in rural Penn-sylvania, surrounded by technicians in obligatory white lab coats and fume hoods leaking an occasional acrid smell, Neil Pearson holds up a plastic model of a chemical compound that resembles a spidery piece of Lego.

Mr Pearson, a 54-year-old

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom